HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Randomised trial of plasma exchange in mild systemic lupus erythematosus.

Abstract
The effects of intensive plasma exchange on the serological and clinical manifestations of mildly active systemic lupus erythematosus were evaluated in a controlled, double-blind trial. Twenty patients were randomised to receive either six 4-litre plasma exchanges or a seemingly identical control procedure over a 2-week period. Plasma exchange produced significant reductions in serum levels of IgG, IgM, IgA, and circulating immune complexes measured by an 125I-Clq binding assay. These serological measures returned to baseline 4 weeks after plasma exchange without a rebound above baseline values. Antibodies to DNA were reduced immediately after plasma exchange; however, they often returned to pre-treatment levels before the next procedure. No changes in any of the serological measures were observed in the control group. In sixteen of the eighteen patients who completed the clinical trial activity had either remained stable or improved; the frequency and degree of clinical improvement was the same in both plasma exchange and control groups.
AuthorsN Wei, J H Klippel, D P Huston, R P Hall, T J Lawley, J E Balow, A D Steinberg, J L Decker
JournalLancet (London, England) (Lancet) Vol. 1 Issue 8314-5 Pg. 17-22 (Jan 01 1983) ISSN: 0140-6736 [Print] England
PMID6129368 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Antigen-Antibody Complex
  • Autoantibodies
  • Immunoglobulins
  • DNA
Topics
  • Adolescent
  • Adult
  • Antigen-Antibody Complex (analysis)
  • Autoantibodies (analysis)
  • Clinical Trials as Topic
  • DNA (immunology)
  • Double-Blind Method
  • Female
  • Humans
  • Immunoglobulins (analysis)
  • Lupus Erythematosus, Systemic (therapy)
  • Male
  • Middle Aged
  • Plasma Exchange
  • Random Allocation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: